InDex Pharmaceuticals Holding AB (publ) announced that CEO Jenny Sundqvist will leave the company per September 26, 2024. Jenny Sundqvist will remain in their positions and at the company's disposal until their last day of employment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.368 SEK | +5.14% | +11.85% | +43.75% |
Apr. 26 | InDex Pharmaceuticals Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 05 | Index Pharmaceuticals Holding AB Announces Board Resignations | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+43.75% | 17.88M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- INDEX Stock
- News InDex Pharmaceuticals Holding AB
- InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024